###begin article-title 0
###xml 14 24 14 24 <italic>Drosophila</italic>
Plasticity of Drosophila Stat DNA binding shows an evolutionary basis for Stat transcription factor preferences
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission.
###end p 1
###begin p 2
###xml 435 445 435 445 <italic>Drosophila</italic>
###xml 495 505 495 505 <italic>Drosophila</italic>
###xml 583 584 583 584 <italic>n</italic>
###xml 590 591 590 591 <italic>n</italic>
###xml 679 680 679 680 <italic>n</italic>
###xml 697 698 697 698 <italic>n</italic>
###xml 904 905 904 905 <italic>n</italic>
###xml 911 912 911 912 <italic>n</italic>
In vertebrates, seven signal transducer and activator of transcription (STAT) proteins bind to palindromic sites separated by spacers of two or three nucleotides (STAT1), four nucleotides (STAT6) or three nucleotides (STAT2 to STAT5a/b). This diversity of binding sites provides specificity to counter semiredundancy and was thought to be a recent evolutionary acquisition. Here, we examine the natural DNA-binding sites of the single Drosophila Stat and show that this is not the case. Rather, Drosophila Stat92E is able to bind to and activate target gene expression through both 3n and 4n spaced sites. Our experiments indicate that Stat92E has a higher binding affinity for 3n sites than for 4n sites and suggest that the levels of target gene expression can be modulated by insertion and/or deletion of single bases. Our results indicate that the ancestral STAT protein had the capacity to bind to 3n and 4n sites and that specific STAT binding preferences evolved with the radiation of the vertebrate STAT family.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 207 220 203 216 <xref ref-type="bibr" rid="b7">Darnell, 1997</xref>
###xml 222 242 218 238 <xref ref-type="bibr" rid="b18">Levy &amp; Darnell, 2002</xref>
###xml 937 942 933 938 <italic>et al</italic>
###xml 927 948 923 944 <xref ref-type="bibr" rid="b16">Kisseleva <italic>et al</italic>, 2002</xref>
###xml 950 970 946 966 <xref ref-type="bibr" rid="b18">Levy &amp; Darnell, 2002</xref>
###xml 1129 1130 1125 1126 <italic>n</italic>
###xml 1141 1142 1137 1138 <italic>n</italic>
###xml 1213 1214 1209 1210 <italic>n</italic>
###xml 1268 1269 1264 1265 <italic>n</italic>
###xml 1303 1304 1299 1300 <italic>n</italic>
###xml 1336 1341 1332 1337 <italic>et al</italic>
###xml 1330 1347 1326 1343 <xref ref-type="bibr" rid="b9">Ehret <italic>et al</italic>, 2001</xref>
The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signalling pathway was originally discovered in vertebrates on the basis of its transduction of activation of gamma-interferon (Darnell, 1997; Levy & Darnell, 2002). Analysis of the pathway rapidly identified a family of seven closely related STATs as well as many pathway-activating cytokines, several receptors and four JAK kinases. The seven STAT transcription factors share several features including an SH2 domain, an invariant tyrosine residue phosphorylated as a result of the activation of STAT, and a characteristic DNA-binding domain. According to the established canonical model, activation of the JAK/STAT pathway by cytokine signalling brings about tyrosine phosphorylation of cytoplasmic STATs and leads to their dimerization. This complex translocates to the nucleus where it binds to DNA, thus activating target gene transcription (Kisseleva et al, 2002; Levy & Darnell, 2002). STAT DNA-binding sites, also known as Gamma interferon activation site (GAS) elements, consist of an essential core comprising the palindromic sequence TTC(n)GAA where n represents a spacer of 2-4 nucleotides. STAT6 shows a preference for 4n spacing, whereas other STATs preferentially bind to 3n, although they can also bind to 2n sites with low affinity (Ehret et al, 2001).
###end p 4
###begin p 5
###xml 90 100 90 100 <italic>Drosophila</italic>
###xml 264 287 264 287 <xref ref-type="bibr" rid="b4">Binari &amp; Perrimon, 1994</xref>
###xml 293 298 293 298 <italic>et al</italic>
###xml 289 304 289 304 <xref ref-type="bibr" rid="b14">Hou <italic>et al</italic>, 1996</xref>
###xml 310 315 310 315 <italic>et al</italic>
###xml 306 321 306 321 <xref ref-type="bibr" rid="b26">Yan <italic>et al</italic>, 1996</xref>
###xml 332 337 332 337 <italic>et al</italic>
###xml 323 343 323 343 <xref ref-type="bibr" rid="b11">Harrison <italic>et al</italic>, 1998</xref>
###xml 351 356 351 356 <italic>et al</italic>
###xml 345 362 345 362 <xref ref-type="bibr" rid="b5">Brown <italic>et al</italic>, 2001</xref>
###xml 369 374 369 374 <italic>et al</italic>
###xml 364 380 364 380 <xref ref-type="bibr" rid="b6">Chen <italic>et al</italic>, 2002</xref>
###xml 390 395 390 395 <italic>et al</italic>
###xml 382 401 382 401 <xref ref-type="bibr" rid="b1">Agaisse <italic>et al</italic>, 2003</xref>
###xml 411 416 411 416 <italic>et al</italic>
###xml 403 422 403 422 <xref ref-type="bibr" rid="b13">Hombr&#237;a <italic>et al</italic>, 2005</xref>
###xml 436 457 436 457 <xref ref-type="bibr" rid="b12">Hombr&#237;a &amp; Brown, 2002</xref>
###xml 469 474 469 474 <italic>et al</italic>
###xml 459 480 459 480 <xref ref-type="bibr" rid="b2">Arbouzova <italic>et al</italic>, 2006</xref>
The Jak/Stat pathways identified in invertebrates seem to be much simpler. Of these, only Drosophila has a 'complete' pathway comprising three unpaired-like cytokines (Upd, Upd2 and Upd3); one receptor (Domeless; Dome); one JAK kinase (Hop) and one Stat (Stat92E; Binari & Perrimon, 1994; Hou et al, 1996; Yan et al, 1996; Harrison et al, 1998; Brown et al, 2001; Chen et al, 2002; Agaisse et al, 2003; Hombria et al, 2005; reviewed in Hombria & Brown, 2002; Arbouzova et al, 2006).
###end p 5
###begin p 6
###xml 0 8 0 8 <italic>In vitro</italic>
###xml 86 96 86 96 <italic>Drosophila</italic>
###xml 143 144 143 144 <italic>n</italic>
###xml 158 163 158 163 <italic>et al</italic>
###xml 154 169 154 169 <xref ref-type="bibr" rid="b26">Yan <italic>et al</italic>, 1996</xref>
###xml 172 179 172 179 <italic>In vivo</italic>
###xml 201 202 201 202 <italic>n</italic>
###xml 231 243 231 243 <italic>even skipped</italic>
###xml 245 248 245 248 <italic>eve</italic>
###xml 262 267 262 267 <italic>et al</italic>
###xml 256 273 256 273 <xref ref-type="bibr" rid="b23">Small <italic>et al</italic>, 1996</xref>
###xml 316 330 316 330 <italic>Drosophila raf</italic>
###xml 332 336 332 336 <italic>Draf</italic>
###xml 384 391 384 391 <italic>Socs36E</italic>
###xml 416 417 416 417 <italic>n</italic>
###xml 456 461 456 461 <italic>et al</italic>
###xml 451 467 451 467 <xref ref-type="bibr" rid="b17">Kwon <italic>et al</italic>, 2000</xref>
###xml 474 479 474 479 <italic>et al</italic>
###xml 469 485 469 485 <xref ref-type="bibr" rid="b3">Baeg <italic>et al</italic>, 2005</xref>
###xml 494 499 494 499 <italic>et al</italic>
###xml 487 505 487 505 <xref ref-type="bibr" rid="b21">M&#252;ller <italic>et al</italic>, 2005</xref>
###xml 533 534 533 534 <italic>n</italic>
###xml 595 618 595 618 <italic>Drosophila melanogaster</italic>
###xml 626 648 626 648 <italic>Caenorhabditis elegans</italic>
###xml 658 663 658 663 <italic>et al</italic>
###xml 650 669 650 669 <xref ref-type="bibr" rid="b10">Gilbert <italic>et al</italic>, 2005</xref>
###xml 671 688 671 688 <xref ref-type="bibr" rid="b24">Wang &amp; Levy, 2006</xref>
###xml 595 618 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 626 648 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
In vitro site selection and electrophoretic mobility shift assays (EMSAs) showed that Drosophila Stat has a binding preference for sites with 3n spacing (Yan et al, 1996). In vivo, Stat92E binding of 3n sites was confirmed for the even skipped (eve) gene (Small et al, 1996). In cell culture, it was also shown that Drosophila raf (Draf) and Suppressor of cytokine signalling at 36E (Socs36E), enhancers containing 3n sites are activated by Jak/Stat (Kwon et al, 2000; Baeg et al, 2005; Muller et al, 2005). Furthermore, vertebrate 3n GAS elements act as reporters for the activation of Stat in Drosophila melanogaster and in Caenorhabditis elegans (Gilbert et al, 2005; Wang & Levy, 2006).
###end p 6
###begin p 7
###xml 53 54 53 54 <italic>n</italic>
###xml 317 327 317 327 <italic>Drosophila</italic>
###xml 376 377 376 377 <italic>n</italic>
###xml 413 414 413 414 <italic>n</italic>
###xml 442 450 442 450 <italic>in vitro</italic>
###xml 484 485 484 485 <italic>n</italic>
###xml 492 493 492 493 <italic>n</italic>
###xml 546 554 546 554 <italic>in vitro</italic>
###xml 559 566 559 566 <italic>in vivo</italic>
These data suggest that the ancestral STAT bound to 3n sites and that the preference for sites with other spacing evolved after the vertebrate STAT radiation. Here, we present evidence that the converse is true, with binding site plasticity of STAT transcription factors representing an ancestral state. We show that Drosophila Stat is able to activate transcription through 4n sites. We show that Stat binds to 3n sites with higher affinity in vitro, and that the transformation of 4n into 3n sites increases the activation of Stat targets both in vitro and in vivo. These observations clarify how the Stat binding preferences evolved and illustrate an unanticipated plasticity of DNA binding that will help in the definition of direct Stat targets outside the vertebrate lineage.
###end p 7
###begin title 8
Results And Discussion
###end title 8
###begin title 9
###xml 18 22 18 22 <italic>dome</italic>
###xml 32 33 32 33 <italic>n</italic>
Stat92E activates dome through 4n sites
###end title 9
###begin p 10
###xml 37 47 37 47 <italic>Drosophila</italic>
###xml 119 123 119 123 <italic>dome</italic>
###xml 147 152 147 152 <italic>et al</italic>
###xml 139 158 139 158 <xref ref-type="bibr" rid="b13">Hombr&#237;a <italic>et al</italic>, 2005</xref>
###xml 218 227 218 227 <italic>dome-MESO</italic>
###xml 264 268 264 268 <italic>dome</italic>
###xml 283 288 283 288 <italic>et al</italic>
###xml 275 294 275 294 <xref ref-type="bibr" rid="b13">Hombr&#237;a <italic>et al</italic>, 2005</xref>
###xml 410 411 410 411 <italic>n</italic>
###xml 420 429 420 429 <italic>dome-MESO</italic>
###xml 431 437 431 437 <xref ref-type="fig" rid="f1">Fig 1A</xref>
###xml 443 448 443 448 <italic>et al</italic>
###xml 439 454 439 454 <xref ref-type="bibr" rid="b26">Yan <italic>et al</italic>, 1996</xref>
###xml 537 541 537 541 <italic>lacZ</italic>
###xml 553 560 553 560 <italic>dome-SB</italic>
###xml 580 581 580 581 <italic>n</italic>
###xml 631 637 631 637 <xref ref-type="fig" rid="f1">Fig 1C</xref>
###xml 692 699 692 699 <italic>dome-SL</italic>
###xml 716 725 716 725 <italic>dome-MESO</italic>
###xml 749 755 749 755 <xref ref-type="fig" rid="f1">Fig 1D</xref>
###xml 851 860 851 860 <italic>dome-SLF2</italic>
###xml 862 870 862 870 <xref ref-type="fig" rid="f1">Fig 1A,E</xref>
###xml 896 897 896 897 <italic>n</italic>
###xml 931 932 931 932 <italic>n</italic>
###xml 1011 1016 1011 1016 <italic>et al</italic>
###xml 1005 1022 1005 1022 <xref ref-type="bibr" rid="b9">Ehret <italic>et al</italic>, 2001</xref>
###xml 1037 1045 1037 1045 <italic>in vitro</italic>
###xml 1109 1110 1109 1110 <italic>n</italic>
###xml 1157 1167 1157 1167 <italic>Drosophila</italic>
###xml 1191 1192 1191 1192 <italic>n</italic>
###xml 1199 1206 1199 1206 <italic>in vivo</italic>
Upd expressed in the ectoderm of the Drosophila pharynx and hindgut signals to the adjacent mesoderm where it enhances dome transcription (Hombria et al, 2005). This effect is mediated by a mesoderm-specific enhancer (dome-MESO) present in the first intron of the dome gene (Hombria et al, 2005). To prove that this enhancer is regulated directly by Stat, we searched for potential Stat92E-binding sites [TTC(3n)GAA] in dome-MESO (Fig 1A; Yan et al, 1996) and identified three such sites at the 3' end of the reporter. However, a 1.2-kb lacZ construct, dome-SB, containing these 3n sites, is unable to drive mesodermal expression (Fig 1C), whereas the complementary 1.6-kb proximal fragment, dome-SL, reproduces the dome-MESO pattern of expression (Fig 1D). The subdivision of this fragment locates the enhancer within a 746-bp fragment that we named dome-SLF2 (Fig 1A,E). Although no canonical 3n sites are present in SLF2, five 4n sites are present-a sequence bound in vertebrates by the STAT6 protein (Ehret et al, 2001). As previous in vitro binding site selection experiments using Stat92E isolated the 3n sites exclusively, we set out to test whether Drosophila Stat92E could bind to 4n sites in vivo.
###end p 10
###begin p 11
###xml 116 120 116 120 <italic>dome</italic>
###xml 147 185 147 185 <xref ref-type="bibr" rid="b8">Drosophila 12 Genomes Consortium, 2007</xref>
###xml 267 282 267 282 <italic>D. melanogaster</italic>
###xml 289 290 289 290 <italic>n</italic>
###xml 298 304 298 304 <xref ref-type="fig" rid="f1">Fig 1B</xref>
###xml 368 372 368 372 <italic>SLF2</italic>
###xml 420 421 420 421 <italic>n</italic>
###xml 437 445 437 445 <italic>SLF2*MUT</italic>
###xml 491 492 491 492 <italic>n</italic>
###xml 542 546 542 546 <italic>SLF4</italic>
###xml 556 560 556 560 <italic>SLF4</italic>
###xml 587 588 587 588 <italic>n</italic>
###xml 604 612 604 612 <italic>SLF4*MUT</italic>
###xml 614 620 614 620 <xref ref-type="fig" rid="f1">Fig 1B</xref>
###xml 267 282 <span type="species:ncbi:7227">D. melanogaster</span>
To identify which of the five potential sites drive mesodermal regulation, we compared the first intron sequence of dome in several Drosophilidae (Drosophila 12 Genomes Consortium, 2007). The only conserved sequence is a 43 bp element containing the third and fourth D. melanogaster Stat 4n sites (Fig 1B). To test the possible function of these two sites, we made an SLF2 construct with the conserved third and fourth 4n sites mutated (SLF2*MUT), a 137-bp fragment containing only the two 4n sites present within the 43 bp conserved region (SLF4), and an SLF4 construct with these two 4n sites mutated (SLF4*MUT; Fig 1B).
###end p 11
###begin p 12
###xml 12 20 12 20 <italic>SLF2*MUT</italic>
###xml 66 67 66 67 <italic>n</italic>
###xml 134 140 134 140 <xref ref-type="fig" rid="f1">Fig 1F</xref>
Analysis of SLF2*MUT shows that mutation of the third and fourth 4n sites results in the almost complete loss of mesoderm expression (Fig 1F), although low levels of expression were still observed at late embryogenesis.
###end p 12
###begin p 13
###xml 4 8 4 8 <italic>SLF4</italic>
###xml 114 118 114 118 <italic>SLF4</italic>
###xml 149 153 149 153 <italic>SLF2</italic>
###xml 222 228 222 228 <xref ref-type="fig" rid="f1">Fig 1G</xref>
###xml 350 356 350 356 <xref ref-type="fig" rid="f2">Fig 2C</xref>
###xml 376 377 376 377 <italic>n</italic>
###xml 387 395 387 395 <italic>SLF4*MUT</italic>
###xml 472 478 472 478 <xref ref-type="fig" rid="f1">Fig 1H</xref>
The SLF4 fragment alone is able to drive expression in the mesoderm of the pharynx and hindgut. The expression of SLF4 is more variable than that of SLF2 with some insertions showing expression exclusively in the pharynx (Fig 1G), whereas others showing low levels of general mesoderm expression in addition to expression in the pharynx and hindgut (Fig 2C). Mutation of the 4n sites in SLF4*MUT is sufficient to ablate all expression in both the pharynx and the hindgut (Fig 1H).
###end p 13
###begin p 14
###xml 34 38 34 38 <italic>SLF4</italic>
###xml 60 64 60 64 <italic>SLF2</italic>
###xml 153 161 153 161 <italic>SLF2*MUT</italic>
###xml 210 211 210 211 <italic>n</italic>
###xml 238 247 238 247 <italic>dome-MESO</italic>
###xml 301 302 301 302 <italic>n</italic>
###xml 312 316 312 316 <italic>SLF2</italic>
###xml 363 371 363 371 <xref ref-type="fig" rid="f1">Fig 1I,J</xref>
The lower levels of expression of SLF4 relative to those of SLF2 in the pharynx and hindgut and the slight remnant expression observed in the pharynx of SLF2*MUT embryos suggest that some of the non-conserved 4n sites might contribute to dome-MESO expression. We tested whether both of the conserved 4n sites in SLF2 are necessary by independently mutating them (Fig 1I,J). Mutation of a single site is not sufficient to abolish mesoderm expression, indicating that these sites are redundant in the context of the SLF2 enhancer.
###end p 14
###begin p 15
###xml 16 20 16 20 <italic>SLF2</italic>
###xml 25 29 25 29 <italic>SLF4</italic>
###xml 100 109 100 109 <italic>Df(1)os1A</italic>
###xml 158 162 158 162 <italic>SLF2</italic>
###xml 216 224 216 224 <xref ref-type="fig" rid="f2">Fig 2A,B</xref>
###xml 251 255 251 255 <italic>SLF4</italic>
###xml 257 265 257 265 <xref ref-type="fig" rid="f2">Fig 2C,D</xref>
###xml 371 379 371 379 <italic>69B-Gal4</italic>
###xml 395 399 395 399 <italic>SLF2</italic>
###xml 401 407 401 407 <xref ref-type="fig" rid="f2">Fig 2E</xref>
###xml 429 433 429 433 <italic>SLF4</italic>
###xml 435 441 435 441 <xref ref-type="fig" rid="f2">Fig 2F</xref>
###xml 508 509 508 509 <italic>n</italic>
###xml 541 549 541 549 <italic>SLF2*MUT</italic>
###xml 551 557 551 557 <xref ref-type="fig" rid="f2">Fig 2G</xref>
###xml 562 570 562 570 <italic>SLF4*MUT</italic>
###xml 572 578 572 578 <xref ref-type="fig" rid="f2">Fig 2H</xref>
To confirm that SLF2 and SLF4 are responsive to Jak/Stat signalling, we studied their expression in Df(1)os1A mutants that lack all Upd ligands. As expected, SLF2 expression disappeared from the pharynx and hindgut (Fig 2A,B) and the same is true for SLF4 (Fig 2C,D). Conversely, ectopic activation of the pathway by expression of Upd or Upd2 using the ectoderm-specific 69B-Gal4 line activates SLF2 (Fig 2E; data not shown) and SLF4 (Fig 2F) in the mesoderm. This ectopic activation requires the conserved 4n sites as it is not observed in SLF2*MUT (Fig 2G) or SLF4*MUT (Fig 2H).
###end p 15
###begin p 16
###xml 4 13 4 13 <italic>dome-MESO</italic>
###xml 173 182 173 182 <italic>dome-MESO</italic>
###xml 373 382 373 382 <xref ref-type="fig" rid="f2">Fig 2I,I&#8242;</xref>
###xml 424 433 424 433 <xref ref-type="fig" rid="f2">Fig 2J,J&#8242;</xref>
###xml 541 545 541 545 <italic>dome</italic>
###xml 634 635 634 635 <italic>n</italic>
###xml 645 654 645 654 <italic>dome-MESO</italic>
The dome-MESO enhancer and its derivatives are expressed specifically in the mesoderm, suggesting that Stat is interacting with tissue-specific cofactors. We tested whether dome-MESO could also be activated in the ectoderm if Upd was co-expressed with various mesoderm-specific proteins. We observed ectopic ectoderm expression after co-expression of Upd with Tinman (Tin; Fig 2I,I'), but not with Dmef2, Bagpipe or Biniou (Fig 2J,J'; data not shown). This suggests that Tin or one of its downstream targets is a STAT cofactor necessary for dome activation in the mesoderm. The requirement for this interaction explains why only the 4n sites in dome-MESO are functional.
###end p 16
###begin title 17
###xml 18 19 18 19 <italic>n</italic>
###xml 25 26 25 26 <italic>n</italic>
Stat92E binds to 4n and 3n sites with different affinity
###end title 17
###begin p 18
###xml 51 52 51 52 <italic>n</italic>
###xml 59 67 59 67 <italic>in vitro</italic>
###xml 120 121 120 121 <italic>n</italic>
###xml 133 134 133 134 <italic>n</italic>
###xml 142 148 142 148 <xref ref-type="fig" rid="f3">Fig 3A</xref>
###xml 310 314 310 314 <sup>Tuml</sup>
###xml 320 325 320 325 <italic>et al</italic>
###xml 316 331 316 331 <xref ref-type="bibr" rid="b20">Luo <italic>et al</italic>, 1995</xref>
###xml 341 346 341 346 <italic>et al</italic>
###xml 333 352 333 352 <xref ref-type="bibr" rid="b15">Karsten <italic>et al</italic>, 2006</xref>
###xml 381 382 381 382 <italic>n</italic>
###xml 408 413 408 413 <italic>et al</italic>
###xml 404 419 404 419 <xref ref-type="bibr" rid="b26">Yan <italic>et al</italic>, 1996</xref>
###xml 473 479 473 479 <xref ref-type="fig" rid="f3">Fig 3B</xref>
###xml 546 552 546 552 <xref ref-type="fig" rid="f3">Fig 3B</xref>
###xml 604 605 604 605 <italic>n</italic>
###xml 617 618 617 618 <italic>n</italic>
###xml 723 729 723 729 <xref ref-type="fig" rid="f3">Fig 3B</xref>
###xml 742 743 742 743 <italic>n</italic>
###xml 808 809 808 809 <italic>n</italic>
###xml 830 838 830 838 <italic>in vitro</italic>
###xml 875 876 875 876 <italic>n</italic>
###xml 932 933 932 933 <italic>n</italic>
###xml 942 943 942 943 <italic>n</italic>
###xml 1014 1015 1014 1015 <italic>n</italic>
###xml 1064 1070 1064 1070 <xref ref-type="fig" rid="f3">Fig 3C</xref>
###xml 1112 1113 1112 1113 <italic>n</italic>
###xml 1166 1167 1166 1167 <italic>n</italic>
###xml 1179 1185 1179 1185 <xref ref-type="fig" rid="f3">Fig 3C</xref>
###xml 1222 1223 1222 1223 <italic>n</italic>
###xml 1256 1257 1256 1257 <italic>n</italic>
###xml 1301 1302 1301 1302 <italic>n</italic>
###xml 1320 1326 1320 1326 <xref ref-type="fig" rid="f3">Fig 3C</xref>
###xml 1377 1378 1377 1378 <italic>n</italic>
###xml 1404 1419 1404 1419 <italic>D. melanogaster</italic>
###xml 1428 1434 1428 1434 <xref ref-type="fig" rid="f1">Fig 1B</xref>
###xml 1455 1461 1455 1461 <xref ref-type="fig" rid="f3">Fig 3C</xref>
###xml 1522 1523 1522 1523 <italic>n</italic>
###xml 1606 1607 1606 1607 <italic>n</italic>
###xml 1404 1419 <span type="species:ncbi:7227">D. melanogaster</span>
To test whether Stat92E can bind to the conserved 4n sites in vitro, oligonucleotides containing these sites (known as 4n Dome3 and 4n Dome4; Fig 3A) were used in EMSAs together with a Stat92E-GFP (green fluorescent protein) fusion protein activated by co-expression of the constitutively active Jak allele HopTuml (Luo et al, 1995; Karsten et al, 2006). By using the established 3n wild-type consensus (Yan et al, 1996) as a positive control, a strong band is detectable (Fig 3B, arrow) that is supershifted by the addition of the GFP antibody (Fig 3B, arrowhead). The same binding conditions with the 4n Dome3 and 4n Dome4 sites also give clear band shifts that can be supershifted (and possibly stabilized) by anti-GFP (Fig 3B). However, 4n band shifts are considerably weaker than those produced by the 3n control under these in vitro conditions. We next tested whether 4n Dome sites could compete with wild-type radiolabelled 3n sites (3n wild type) for binding to activated Stat92E-GFP. Although unlabelled 3n wild-type-binding sites are strong competitors (Fig 3C, lanes 1-3), a 50-fold excess of mutant 3n-binding sites is not able to compete with labelled 3n wild type (Fig 3C, lane 14). By contrast, unlabelled 4n Dome3 and, to a lesser extent, 4n Dome4 sites can compete with the labelled 3n wild-type probe (Fig 3C, lanes 6 and 9). A Dome3+4 probe containing both 4n sites separated by their D. melanogaster spacer (Fig 1B) at 25-fold excess (Fig 3C, lane 12-a concentration that provides a 50-fold excess of 4n sites) produces stronger competition than the equivalent concentration of either 4n site alone, suggesting that two adjacent sites are able to bind Stat92E better than a single binding site in isolation.
###end p 18
###begin p 19
###xml 11 18 11 18 <italic>in vivo</italic>
###xml 175 176 175 176 <italic>n</italic>
###xml 182 183 182 183 <italic>n</italic>
###xml 199 205 199 205 <xref ref-type="fig" rid="f3">Fig 3D</xref>
###xml 262 265 262 265 <sub>167</sub>
###xml 291 296 291 296 <italic>et al</italic>
###xml 284 302 284 302 <xref ref-type="bibr" rid="b21">M&#252;ller <italic>et al</italic>, 2005</xref>
###xml 388 392 388 392 <sup>Tuml</sup>
###xml 398 403 398 403 <italic>et al</italic>
###xml 394 409 394 409 <xref ref-type="bibr" rid="b20">Luo <italic>et al</italic>, 1995</xref>
###xml 442 443 442 443 <italic>n</italic>
###xml 449 450 449 450 <italic>n</italic>
###xml 548 549 548 549 <italic>n</italic>
###xml 590 591 590 591 <italic>n</italic>
###xml 602 608 602 608 <xref ref-type="fig" rid="f3">Fig 3E</xref>
###xml 638 640 638 640 <italic>SB</italic>
###xml 642 643 642 643 <italic>n</italic>
###xml 651 658 651 658 <xref ref-type="fig" rid="f1">Figs 1A</xref>
###xml 660 662 660 662 <xref ref-type="fig" rid="f3">3A</xref>
###xml 684 692 684 692 <italic>in vitro</italic>
###xml 694 700 694 700 <xref ref-type="fig" rid="f3">Fig 3F</xref>
###xml 769 776 769 776 <italic>in vivo</italic>
To measure in vivo the relative transcriptional activation potential of activated Stat92E-GFP at these sites, we devised a luciferase reporter plasmid containing either four 3n- or 4n-binding sites (Fig 3D; Methods). By using these reporters in an established Kc167 cell-based model (Muller et al, 2005), we stimulated cells by either co-expressing the Upd ligand or the activated Jak HopTuml (Luo et al, 1995). Under these conditions, both 3n and 4n reporters show significantly increased levels of activity over the unstimulated state, with the 3n reporter around twice as active as the 4n reporter (Fig 3E). Finally, we found that the SB 3n sites (Figs 1A, 3A) can bind to Stat92E in vitro (Fig 3F), underscoring the importance of cofactors for the activity of Stat in vivo.
###end p 19
###begin p 20
###xml 66 72 66 72 <xref ref-type="fig" rid="f1">Fig 1B</xref>
###xml 112 127 112 127 <italic>D. melanogaster</italic>
###xml 139 140 139 140 <italic>n</italic>
###xml 180 181 180 181 <italic>n</italic>
###xml 281 282 281 282 <italic>n</italic>
###xml 306 307 306 307 <italic>n</italic>
###xml 502 503 502 503 <italic>n</italic>
###xml 514 518 514 518 <italic>SLF4</italic>
###xml 525 526 525 526 <italic>n</italic>
###xml 553 560 553 560 <italic>obscura</italic>
###xml 628 643 628 643 <italic>D. melanogaster</italic>
###xml 653 657 653 657 <italic>SLF4</italic>
###xml 659 667 659 667 <xref ref-type="fig" rid="f4">Fig 4A,B</xref>
###xml 808 809 808 809 <italic>n</italic>
###xml 824 835 824 835 <italic>D. virilis,</italic>
###xml 894 898 894 898 <italic>SLF4</italic>
###xml 909 915 909 915 <xref ref-type="fig" rid="f4">Fig 4C</xref>
###xml 978 979 978 979 <italic>n</italic>
###xml 995 996 995 996 <italic>n</italic>
###xml 112 127 <span type="species:ncbi:7227">D. melanogaster</span>
###xml 553 566 <span type="species:ncbi:32355">obscura group</span>
###xml 628 643 <span type="species:ncbi:7227">D. melanogaster</span>
###xml 824 834 <span type="species:ncbi:7244">D. virilis</span>
Comparison of the conserved SLF4 region in various Drosophilidae (Fig 1B) shows that species closely related to D. melanogaster share the 4n spacing of the Stat fourth site, with 3n sites present in more distantly related drosophilids. In some species in which the fourth site is 3n, the third site has a 2n spacer. The above experiments suggest that changes in spacer length during evolution might modulate the levels of transcription of target genes. To test this possibility, we mutated the fourth 4n spacer in SLF4 to a 3n spacer as observed in the obscura group. The resulting enhancer drove higher levels of expression in D. melanogaster than did SLF4 (Fig 4A,B), indicated by the consistent appearance of hindgut expression in all insertions. Further mutation in this enhancer of the third-site to a 2n spacer, as in D. virilis, restored the levels of expression similar to the original SLF4 enhancer (Fig 4C). These results indicate that varying the relative number of 3n compared with 4n sites might control the level of expression of Stat targets during evolution.
###end p 20
###begin title 21
###xml 23 26 23 26 <italic>crb</italic>
###xml 49 50 49 50 <italic>n</italic>
The direct Stat target crb is regulated through 4n sites
###end title 21
###begin p 22
###xml 27 37 27 37 <italic>Drosophila</italic>
###xml 80 81 80 81 <italic>n</italic>
###xml 120 123 120 123 <italic>crb</italic>
###xml 152 160 152 160 <xref ref-type="fig" rid="f5">Fig 5A,B</xref>
###xml 172 177 172 177 <italic>et al</italic>
###xml 162 183 162 183 <xref ref-type="bibr" rid="b19">Lovegrove <italic>et al</italic>, 2006</xref>
###xml 255 256 255 256 <italic>n</italic>
###xml 266 267 266 267 <italic>n</italic>
###xml 283 286 283 286 <italic>crb</italic>
###xml 308 314 308 314 <xref ref-type="fig" rid="f5">Fig 5C</xref>
###xml 334 335 334 335 <italic>n</italic>
###xml 390 396 390 396 <xref ref-type="fig" rid="f5">Fig 5D</xref>
###xml 425 426 425 426 <italic>n</italic>
###xml 434 440 434 440 <xref ref-type="fig" rid="f5">Fig 5E</xref>
###xml 528 529 528 529 <italic>n</italic>
###xml 535 536 535 536 <italic>n</italic>
To determine whether other Drosophila Stat target genes are controlled through 4n sites, we analysed the Stat-dependent crb spiracle-specific enhancer (Fig 5A,B; Lovegrove et al, 2006). Simultaneous mutation of the three putative Stat-binding sites (one 3n and two 4n sites) reduces crb spiracle expression (Fig 5C). Mutation of the 3n site has little effect on the expression of enhancer (Fig 5D), whereas mutation of both 4n sites (Fig 5E) results in levels of expression similar to those obtained after mutation of both the 3n and 4n sites.
###end p 22
###begin p 23
###xml 59 67 59 67 <italic>in vitro</italic>
###xml 222 229 222 229 <italic>in vivo</italic>
Our results highlight the limitations of bioinformatic and in vitro DNA-binding analyses as sole methods for defining transcription-factor-binding sites if they overlook low-affinity binding sites that might be functional in vivo because of tissue-specific cofactors.
###end p 23
###begin p 24
###xml 16 26 16 26 <italic>Drosophila</italic>
###xml 58 59 58 59 <italic>n</italic>
###xml 65 66 65 66 <italic>n</italic>
###xml 188 198 188 198 <italic>Drosophila</italic>
###xml 273 283 273 283 <italic>Drosophila</italic>
###xml 498 499 498 499 <italic>n</italic>
###xml 515 516 515 516 <italic>n</italic>
###xml 732 737 732 737 <italic>et al</italic>
###xml 725 743 725 743 <xref ref-type="bibr" rid="b22">Seidel <italic>et al</italic>, 1995</xref>
###xml 857 867 857 867 <italic>Drosophila</italic>
###xml 927 932 927 932 <italic>et al</italic>
###xml 924 938 924 938 <xref ref-type="bibr" rid="b25">Xi <italic>et al</italic>, 2003</xref>
The capacity of Drosophila Stat to activate through both 3n and 4n sites suggests that the ancestral Stat protein had the ability to bind to both sites. This capacity has been retained in Drosophila and possibly in other invertebrates. Intriguingly, this suggests that the Drosophila Stat protein dimer has some flexibility in its ability to bind to DNA sites with different spacing. The loss of this flexibility after the radiation of the vertebrate STATs might have resulted in the differential 3n compared with 4n binding preferences observed in mammalian STAT proteins. In vertebrates, the specialization of various STAT proteins for different binding sites might have been advantageous for acquiring target specificity (Seidel et al, 1995), although it is possible that vertebrate STATs can also activate targets through low binding affinity sites. In Drosophila, in which it has been shown that Upd acts as morphogen (Xi et al, 2003), maintaining Stat binding flexibility might be advantageous, as the evolution of the number of Stat-binding sites and their spacer length could provide a flexible system to modulate the distance from the source at which a given Stat target could be activated.
###end p 24
###begin title 25
Methods
###end title 25
###begin p 26
###xml 0 36 0 36 <bold>Constructs and directed mutagenesis.</bold>
###xml 79 88 79 88 <italic>phs43lacZ</italic>
###xml 129 138 129 138 <italic>dome-MESO</italic>
###xml 173 178 173 178 <italic>et al</italic>
###xml 165 184 165 184 <xref ref-type="bibr" rid="b13">Hombr&#237;a <italic>et al</italic>, 2005</xref>
###xml 220 223 220 223 <italic>Eco</italic>
###xml 226 229 226 229 <italic>Bam</italic>
###xml 247 250 247 250 <italic>Not</italic>
###xml 252 255 252 255 <italic>Eco</italic>
###xml 522 527 522 527 <italic>pGEMT</italic>
###xml 548 557 548 557 <italic>phs43lacZ</italic>
Constructs and directed mutagenesis. All reporter constructs were generated in phs43lacZ. To create the SB and SL reporters, the dome-MESO 2.8-kb enhancer fragment (Hombria et al, 2005) was subdivided into a distal (SB) EcoRV-BamH1 and a proximal NotI-EcoRV (SL) fragment. PCR amplification of the SL fragment with the primers TAGGAGGGGAACTGGGATGG and ATGTTTGGCCTCGAAATTGC generated 746 bp SLF2. Amplification with CGAATACGTTAGGGCGAGCC and GTACATCGGCACTTCGGACG created 138 bp SLF4. Amplified fragments were subcloned into pGEMT and from there into phs43lacZ.
###end p 26
###begin p 27
###xml 47 55 47 55 <italic>in vitro</italic>
###xml 81 83 81 83 <underline>TT</underline>
###xml 105 107 105 107 <underline>AA</underline>
###xml 134 140 134 140 <xref ref-type="fig" rid="f1">Fig 1B</xref>
###xml 227 228 227 228 <sup>*</sup>
###xml 240 241 240 241 <sup>*</sup>
###xml 415 416 415 416 <italic>n</italic>
###xml 417 418 417 418 <italic>n</italic>
###xml 504 505 504 505 <italic>n</italic>
###xml 506 507 506 507 <italic>n</italic>
The conserved Stat sites in SLF4 and SLF2 were in vitro mutagenized into TTCCGCTGTT, the third site, and AACGTCCGAA, the fourth site (Fig 1B), using QuikChange (Stratagene; ) and appropriate PAGE-purified primers to create SLF2*MUT and SLF4*MUT. These sites were mutated independently in SLF2 to create SLF2MUT3rd and SLF2MUT4th. The same sites were also mutated to create various spacer variants of SLF4. In SLF4 4n3n, the fourth site was mutated to TTC.TCCGAA where (.) indicates a deleted G. In SLF4 2n3n, apart from this deletion, the third site was mutated to TTCC..TGAA where (..) indicates deleted GC.
###end p 27
###begin p 28
###xml 128 133 128 133 <italic>et al</italic>
###xml 118 139 118 139 <xref ref-type="bibr" rid="b19">Lovegrove <italic>et al</italic>, 2006</xref>
###xml 197 199 197 199 <underline>CC</underline>
###xml 206 207 206 207 <italic>n</italic>
###xml 218 220 218 220 <underline>TT</underline>
###xml 230 231 230 231 <italic>n</italic>
###xml 245 247 245 247 <underline>TT</underline>
###xml 257 258 257 258 <italic>n</italic>
###xml 269 270 269 270 <italic>n</italic>
###xml 292 293 292 293 <italic>n</italic>
###xml 294 295 294 295 <italic>n</italic>
###xml 303 304 303 304 <italic>n</italic>
###xml 321 323 321 323 <underline>TT</underline>
###xml 340 341 340 341 <italic>n</italic>
###xml 361 362 361 362 <italic>n</italic>
###xml 406 408 406 408 <underline>TT</underline>
###xml 414 415 414 415 <italic>n</italic>
###xml 429 431 429 431 <underline>TT</underline>
###xml 437 438 437 438 <italic>n</italic>
###xml 548 549 545 546 <sup>*</sup>
###xml 561 562 558 559 <sup>*</sup>
###xml 698 703 695 700 <italic>et al</italic>
###xml 690 710 687 707 <xref ref-type="bibr" rid="b13">Hombr&#237;a <italic>et al</italic> (2005)</xref>
###xml 712 721 709 718 <italic>Df(1)os1A</italic>
The wild-type crb43.2 enhancer and the triple mutant Stat-binding-site spiracle enhancer have been described earlier (Lovegrove et al, 2006). The mutations in the triple mutant (- - -) were TTCCATGCC (for 3n), TTCGTTTGTT (for 5' 4n) and TTCAGGGGTT (for 3' 4n). In the 3n mutated construct (-4n4n), the 3n site was TTCCATGTT. In the double 4n mutant construct (3n- -), the sites were transformed to TTCGTTTGTT (5' 4n) and TTCAGGGGTT (3' 4n). For each construct, several independent inserts were analysed using anti-beta-galactosidase. For SLF4, SLF2*MUT and SLF4*MUT, 10 inserts were studied in each case to confirm that the expression was consistent. All fly strains have been described by Hombria et al (2005). Df(1)os1A is a deletion for all three Upd ligands (Upd, Upd2 and Upd3).
###end p 28
###begin p 29
###xml 0 38 0 38 <bold>Electrophoretic mobility shift assays.</bold>
###xml 118 123 118 123 <italic>et al</italic>
###xml 110 130 110 130 <xref ref-type="bibr" rid="b15">Karsten <italic>et al</italic> (2006)</xref>
###xml 233 234 233 234 <italic>n</italic>
###xml 289 290 289 290 <italic>n</italic>
###xml 401 402 401 402 <italic>n</italic>
###xml 457 458 457 458 <italic>n</italic>
###xml 509 510 509 510 <italic>n</italic>
###xml 561 562 561 562 <italic>n</italic>
###xml 613 614 613 614 <italic>n</italic>
###xml 673 674 673 674 <italic>n</italic>
###xml 800 802 800 802 <sup>32</sup>
###xml 915 923 911 919 <xref ref-type="fig" rid="f3">Fig 3B,F</xref>
###xml 984 986 979 981 <sup>&#8722;1</sup>
###xml 1090 1096 1080 1086 <xref ref-type="fig" rid="f3">Fig 3C</xref>
###xml 1138 1139 1128 1129 <italic>n</italic>
###xml 1247 1248 1237 1238 <italic>n</italic>
###xml 1320 1322 1309 1311 <sup>&#8722;1</sup>
Electrophoretic mobility shift assays. EMSAs to detect DNA binding of Stat92E were undertaken as described by Karsten et al (2006). Double-stranded DNA probes were generated by annealing GGAGGGTTCCGCTGAAAAT and GACATTTTCAGCGGAACCC (4n Dome3), GGACAATTCGTCCGAAGTG and GACCACTTCGGACGAATTG (4n Dome4), GGAGGGTTCCGCTGAAAATGTTTATTTTTAACAATTCGTCCGAAGTG and GACCACTTCGGACGAATTGTTAAAAATAAACATTTTCAGCGGAACCC (4n Dome3+4), GGAATTTTCATAGAATCA and GACTGATTCTATGAAAAT (3n SB1), GGAGGTTTCATGGAAATC and GACGATTTCCATGAAACC (3n SB2), GGACGATTCCGAGAACTG and GACCAGTTCTCGGAATCG (3n SB3), GGATTTTTCCCGGAAATG and GACCATTTCCGGGAAAAA (3n wild type) or GGATTTTTGCCGCAAATG and GACCATTTGCGGCAAAAA (3n MUT). The recessed ends of annealed oligonucleotide pairs were filled in using Klenow polymerase and dNTPs containing either 32P-gamma-dCTP (to generate radioactive probes) or unlabelled dNTPs (to generate cold competitors). EMSAs shown in Fig 3B,F used 0.15 pmol of radiolabelled probe per lane and 50 mug ml-1 poly dI-dC, whereas supershifts included 0.3 mul alpha-GFP antibody (Abcam; ). For competition assays (Fig 3C), binding to 0.06 pmol of radiolabelled 3n wild-type probe was assayed in the presence of either 0, 0.6 or 3 pmol of unlabelled Dome3, Dome4, 3 pmol 3n MUT or 0.3, 1.5 or 3 pmol of Dome3+4 added as competitor with 83 mug ml-1 poly dI-dC.
###end p 29
###begin p 30
###xml 0 18 0 18 <bold>Luciferase assays.</bold>
###xml 23 33 23 33 <italic>2x2Draf 3n</italic>
###xml 77 81 77 81 <italic>Draf</italic>
###xml 84 87 84 87 <italic>luc</italic>
###xml 115 116 115 116 <italic>n</italic>
###xml 142 147 142 147 <italic>et al</italic>
###xml 137 153 137 153 <xref ref-type="bibr" rid="b17">Kwon <italic>et al</italic>, 2000</xref>
###xml 214 215 214 215 <italic>n</italic>
###xml 267 271 267 271 <italic>Draf</italic>
###xml 274 286 274 286 <italic>luc in vitro</italic>
###xml 401 402 401 402 <italic>n</italic>
###xml 428 429 428 429 <italic>n</italic>
Luciferase assays. The 2x2Draf 3n luciferase reporter is based on the p5'-663Drafwt-luc originally containing two 3n Stat-binding sites (Kwon et al, 2000) that we duplicated to generate a reporter containing four 3n sites. We also generated another version of p5'-663Drafwt-luc in vitro which was mutated to include another spacer nucleotide that we duplicated to generate a reporter containing four 4n sites (known as 2x2Draf 4n).
###end p 30
###begin p 31
###xml 23 24 23 24 <italic>n</italic>
###xml 29 30 29 30 <italic>n</italic>
###xml 51 59 51 59 <italic>in vitro</italic>
###xml 139 142 139 142 <underline>TTC</underline>
###xml 143 144 143 144 <bold>T</bold>
###xml 146 149 146 149 <underline>GAA</underline>
###xml 159 162 159 162 <underline>TTC</underline>
###xml 163 164 163 164 <bold>T</bold>
###xml 166 169 166 169 <underline>GAA</underline>
###xml 204 207 204 207 <underline>TTC</underline>
###xml 209 210 209 210 <bold>A</bold>
###xml 211 214 211 214 <underline>GAA</underline>
###xml 224 227 224 227 <underline>TTC</underline>
###xml 229 230 229 230 <bold>A</bold>
###xml 231 234 231 234 <underline>GAA</underline>
###xml 365 366 365 366 <italic>n</italic>
###xml 392 393 392 393 <italic>n</italic>
###xml 464 467 464 467 <italic>Bam</italic>
###xml 474 477 474 477 <italic>Xba</italic>
###xml 536 539 536 539 <italic>Sma</italic>
###xml 562 563 562 563 <italic>n</italic>
###xml 577 578 577 578 <italic>n</italic>
###xml 666 669 666 669 <sub>167</sub>
###xml 699 704 699 704 <italic>et al</italic>
###xml 692 711 692 711 <xref ref-type="bibr" rid="b21">M&#252;ller <italic>et al</italic> (2005)</xref>
###xml 739 740 739 740 <italic>n</italic>
###xml 746 747 746 747 <italic>n</italic>
Transformation of the 3n to 4n sites was generated in vitro using the QuikChange method (Stratagene) and the oligonucleotides GGGGATCCTAAAATTCGTCGGAAAGTAATAAAATTCGTCGGAAAGTAAAGATCCCCCG and CGGGGGATCTTTACTTTCCGACGAATTTTATTACTTTCCGACGAATTTTAGGATCCCC (underlined bases represent the core Stat92E-binding sequence and bold indicates the added base). Both the original 3n and the newly generated 4n vectors were then multimerized by cutting out the binding sites using BamHI and XbaI, filling in and re-ligating into the parental vector cut SmaI to generate 2x2Draf 3n and 2x2Draf 4n, respectively. Constructs were sequence verified. Activity assays were undertaken in Kc167 cells as described by Muller et al (2005). Equal quantities of both 3n and 4n reporters were transfected for each experiment repeated in quadruplicate and normalized to unstimulated background activity.
###end p 31
###begin p 32
We thank Stephen Brown, Fernando Casares and Sol Sotillos for comments on the paper; Manfred Frasch and Michael Taylor for stocks; Nan Hu, Kirsty Johnstone and Sabine Hader for technical assistance. J.C.-G.H. was supported by Junta de Andalucia, Ministerio de Educacion y Ciencia, Consolider and the European Regional Development Fund (ERDF); M.P.Z. by the Deutsche Forschungsgemeinschaft (DFG), the Max Planck Society and The Royal Society. M.P.Z. is a Cancer Research-UK Senior Cancer Research Fellow.
###end p 32
###begin p 33
The authors declare that they have no conflict of interest.
###end p 33
###begin article-title 34
###xml 31 41 31 41 <italic>Drosophila</italic>
Signaling role of hemocytes in Drosophila JAK/STAT-dependent response to septic injury.
###end article-title 34
###begin article-title 35
Ken & barbie selectively regulates the expression of a subset of Jak/STAT pathway target genes.
###end article-title 35
###begin article-title 36
###xml 62 72 62 72 <italic>Drosophila</italic>
Genome-wide RNAi analysis of JAK/STAT signaling components in Drosophila.
###end article-title 36
###begin article-title 37
###xml 101 111 101 111 <italic>Drosophila</italic>
Stripe-specific regulation of pair-rule genes by hopscotch, a putative Jak family tyrosine kinase in Drosophila.
###end article-title 37
###begin article-title 38
###xml 76 86 76 86 <italic>Drosophila</italic>
Identification of the first invertebrate interleukin JAK/STAT receptor, the Drosophila gene domeless.
###end article-title 38
###begin article-title 39
###xml 0 3 0 3 <italic>mom</italic>
###xml 34 44 34 44 <italic>Drosophila</italic>
mom identifies a receptor for the Drosophila JAK/STAT signal transduction pathway and encodes a protein distantly related to the mammalian cytokine receptor family.
###end article-title 39
###begin article-title 40
STATs and gene regulation.
###end article-title 40
###begin article-title 41
###xml 38 48 38 48 <italic>Drosophila</italic>
Evolution of genes and genomes on the Drosophila phylogeny.
###end article-title 41
###begin article-title 42
###xml 66 74 66 74 <italic>in vitro</italic>
DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites.
###end article-title 42
###begin article-title 43
###xml 36 46 36 46 <italic>Drosophila</italic>
###xml 94 101 94 101 <italic>in vivo</italic>
A novel functional activator of the Drosophila JAK/STAT pathway, unpaired2, is revealed by an in vivo reporter of pathway activation.
###end article-title 43
###begin article-title 44
###xml 0 10 0 10 <italic>Drosophila</italic>
Drosophila unpaired encodes a secreted protein that activates the JAK signaling pathway.
###end article-title 44
###begin article-title 45
###xml 21 31 21 31 <italic>Drosophila</italic>
The fertile field of Drosophila Jak/STAT signalling.
###end article-title 45
###begin article-title 46
###xml 28 38 28 38 <italic>Drosophila</italic>
Characterisation of Upd2, a Drosophila JAK/STAT pathway ligand.
###end article-title 46
###begin article-title 47
###xml 31 41 31 41 <italic>Drosophila</italic>
Marelle acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs.
###end article-title 47
###begin article-title 48
###xml 74 84 74 84 <italic>Drosophila</italic>
Mutational analysis reveals separable DNA binding and trans-activation of Drosophila STAT92E.
###end article-title 48
###begin article-title 49
Signaling through the JAK/STAT pathway, recent advances and future challenges.
###end article-title 49
###begin article-title 50
###xml 34 44 34 44 <italic>Drosophila</italic>
###xml 67 77 67 77 <italic>Drosophila</italic>
Transcriptional regulation of the Drosophila raf proto-oncogene by Drosophila STAT during development and in immune response.
###end article-title 50
###begin article-title 51
Stats: transcriptional control and biological impact.
###end article-title 51
###begin article-title 52
###xml 104 114 104 114 <italic>Drosophila</italic>
Coordinated control of cell adhesion, polarity, and cytoskeleton underlies Hox-induced organogenesis in Drosophila.
###end article-title 52
###begin article-title 53
###xml 34 44 34 44 <italic>Drosophila</italic>
An amino acid substitution in the Drosophila hopTum-l Jak kinase causes leukemia-like hematopoietic defects.
###end article-title 53
###begin article-title 54
Identification of JAK/STAT signalling components by genome-wide RNA interference.
###end article-title 54
###begin article-title 55
Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity.
###end article-title 55
###begin article-title 56
###xml 64 74 64 74 <italic>Drosophila</italic>
Regulation of two pair-rule stripes by a single enhancer in the Drosophila embryo.
###end article-title 56
###begin article-title 57
###xml 0 10 0 10 <italic>C. elegans</italic>
###xml 0 10 <span type="species:ncbi:6239">C. elegans</span>
C. elegans STAT: evolution of a regulatory switch.
###end article-title 57
###begin article-title 58
A gradient of JAK pathway activity patterns the anterior-posterior axis of the follicular epithelium.
###end article-title 58
###begin article-title 59
###xml 48 58 48 58 <italic>Drosophila</italic>
Identification of a Stat gene that functions in Drosophila development.
###end article-title 59
###begin p 60
###xml 15 19 15 19 <italic>dome</italic>
###xml 43 44 43 44 <italic>n</italic>
###xml 53 54 53 54 <bold>A</bold>
###xml 88 92 88 92 <italic>dome</italic>
###xml 212 213 212 213 <italic>n</italic>
###xml 224 225 224 225 <italic>n</italic>
###xml 239 240 239 240 <bold>B</bold>
###xml 270 274 270 274 <italic>SLF4</italic>
###xml 418 419 418 419 <italic>n</italic>
###xml 420 421 420 421 <italic>n</italic>
###xml 430 431 430 431 <italic>n</italic>
###xml 432 433 432 433 <italic>n</italic>
###xml 448 449 448 449 <italic>n</italic>
###xml 450 451 450 451 <italic>n</italic>
###xml 578 586 578 586 <italic>SLF2*MUT</italic>
###xml 591 599 591 599 <italic>SLF4*MUT</italic>
###xml 602 603 602 603 <bold>C</bold>
###xml 609 611 609 611 <italic>SB</italic>
###xml 650 651 650 651 <italic>n</italic>
###xml 703 705 703 705 <italic>SL</italic>
###xml 707 708 707 708 <bold>D</bold>
###xml 718 722 718 722 <italic>SLF2</italic>
###xml 724 725 724 725 <bold>E</bold>
###xml 783 784 783 784 <bold>F</bold>
###xml 864 872 864 872 <italic>SLF2*MUT</italic>
###xml 973 974 973 974 <bold>G</bold>
###xml 980 984 980 984 <italic>SLF4</italic>
###xml 1152 1153 1152 1153 <bold>G</bold>
###xml 1159 1165 1159 1165 <xref ref-type="fig" rid="f2">Fig 2C</xref>
###xml 1169 1170 1169 1170 <bold>H</bold>
###xml 1252 1260 1252 1260 <italic>SLF4*MUT</italic>
###xml 1465 1469 1465 1469 <italic>SLF2</italic>
###xml 1494 1495 1494 1495 <bold>I</bold>
###xml 1517 1518 1517 1518 <bold>J</bold>
###xml 1584 1588 1584 1588 <italic>SLF2</italic>
###xml 1593 1594 1593 1594 <bold>E</bold>
###xml 1602 1604 1602 1604 <bold>I)</bold>
###xml 1610 1611 1610 1611 <bold>J</bold>
###xml 1640 1641 1640 1641 <bold>F</bold>
###xml 1658 1659 1658 1659 <bold>B</bold>
Stat regulates dome transcription through 4n sites. (A) Schematic representation of the dome gene showing the localization of the putative Stat-binding sites. Sites in the first intron are represented by black (3n) or red (4n) asterisks. (B) Comparison of the conserved SLF4 region in several Drosophilidae. The element has two putative Stat sites with varying spacer lengths as indicated by the tree branch colours (4n4n (red), 4n3n (orange) and 2n3n (green)). Asterisks under the sequence label the putative Stat-binding sites and red dashes indicate the mutated bases in the SLF2*MUT and SLF4*MUT. (C) The SB first intron fragment containing the 3n sites does not drive expression in the embryo. The SL (D) and the SLF2 (E) fragments drive expression in the pharynx and hindgut. (F) Simultaneous mutation of the conserved third and fourth Stat-binding sites in SLF2*MUT abolishes most expression from the pharynx and hindgut, although low levels remain at late stages. (G) The SLF4 fragment drives expression, albeit at low levels, in the pharynx and hindgut. Hindgut expression is only observed in inserts with higher levels of expression (compare G with Fig 2C). (H) Mutation of both Stat-binding sites abolishes pharynx and hindgut expression in SLF4*MUT. This particular line has been chosen as it has Jak/Stat-independent expression in the amnioserosa (white arrow) that acts as an internal control for staining. Mutation of only one conserved Stat site in SLF2, either the third site (I) or the fourth site (J), is not sufficient to abolish the expression (compare wild-type SLF2 in (E) with (I) and (J) with the double mutant in (F)). The tree in (B) is modified from the assembly, alignment and annotation of 12 species as published in FlyBase. Stat, signal transducer and activator of transcription.
###end p 60
###begin p 61
###xml 14 18 14 18 <italic>SLF2</italic>
###xml 23 27 23 27 <italic>SLF4</italic>
###xml 67 68 67 68 <bold>A</bold>
###xml 73 77 73 77 <italic>SLF2</italic>
###xml 174 175 174 175 <bold>B</bold>
###xml 203 204 203 204 <bold>A</bold>
###xml 211 220 211 220 <italic>Df(1)os1A</italic>
###xml 240 243 240 243 <italic>upd</italic>
###xml 410 411 410 411 <bold>C</bold>
###xml 425 429 425 429 <italic>SLF4</italic>
###xml 449 450 449 450 <bold>D</bold>
###xml 476 485 476 485 <italic>Df(1)os1A</italic>
###xml 499 500 499 500 <bold>E</bold>
###xml 501 502 501 502 <bold>F</bold>
###xml 512 515 512 515 <italic>upd</italic>
###xml 546 554 546 554 <italic>69B-Gal4</italic>
###xml 582 583 582 583 <bold>E</bold>
###xml 594 595 594 595 <bold>F</bold>
###xml 626 627 626 627 <bold>G</bold>
###xml 628 629 628 629 <bold>H</bold>
###xml 639 642 639 642 <italic>upd</italic>
###xml 738 746 738 746 <italic>SLF2*MUT</italic>
###xml 748 749 748 749 <bold>G</bold>
###xml 757 765 757 765 <italic>SLF4*MUT</italic>
###xml 767 768 767 768 <bold>H</bold>
###xml 772 773 772 773 <bold>I</bold>
###xml 818 821 818 821 <italic>upd</italic>
###xml 826 829 826 829 <italic>tin</italic>
###xml 843 852 843 852 <italic>dome-MESO</italic>
###xml 871 872 871 872 <bold>J</bold>
###xml 901 904 901 904 <italic>upd</italic>
###xml 909 914 909 914 <italic>Dmef2</italic>
###xml 952 961 952 961 <italic>dome-MESO</italic>
###xml 980 982 980 982 <bold>I&#8242;</bold>
###xml 983 985 983 985 <bold>J&#8242;</bold>
###xml 1041 1042 1041 1042 <bold>I</bold>
###xml 1043 1044 1043 1044 <bold>J</bold>
###xml 1297 1306 1297 1306 <italic>dome-MESO</italic>
###xml 1308 1343 1308 1343 <italic>domeless-mesoderm-specific enhancer</italic>
Expression of SLF2 and SLF4 depends on Jak/Stat pathway activity. (A) An SLF2 line in wild type. This insertion has expression on the amnioserosa unrelated to the enhancer. (B) The same insertion as in (A) in a Df(1)os1A embryo lacking all upd genes. The expression in the pharynx and hindgut disappears, whereas the unrelated amnioserosa staining persists, acting as an internal control for staining levels. (C) A wild-type SLF4 strong insertion. (D) The same insertion in a Df(1)os1A background. (E,F) Ectopic upd in the ectoderm driven by the 69B-Gal4 line induces ectopic SLF2 (E) or SLF4 (F) expression in the mesoderm. (G,H) Ectopic upd does not induce ectopic expression when the two conserved Stat-binding sites are mutated as in SLF2*MUT (G) or in SLF4*MUT (H). (I) Simultaneous expression in the ectoderm of upd and tin can activate dome-MESO in the ectoderm. (J) Simultaneous expression of upd and Dmef2 does not result in the activation of dome-MESO in the ectoderm. (I',J') Close-up views of the ventral side of the embryos in (I,J) showing the position of the ectoderm and mesoderm cells. Only Upd and Tin co-expression can activate the enhancer in the ectoderm. In both cases, because of the presence of the endogenous mesodermal cofactors, there is mesodermal enhancer expression. dome-MESO, domeless-mesoderm-specific enhancer; Jak, Janus kinase; Stat, signal transducer and activator of transcription.
###end p 61
###begin p 62
###xml 0 10 0 10 <italic>Drosophila</italic>
###xml 26 27 26 27 <italic>n</italic>
###xml 33 34 33 34 <italic>n</italic>
###xml 67 68 67 68 <bold>A</bold>
###xml 113 114 113 114 <bold>B</bold>
###xml 115 116 115 116 <bold>C</bold>
###xml 117 118 117 118 <bold>F</bold>
###xml 213 219 213 219 <xref ref-type="fig" rid="f1">Fig 1A</xref>
###xml 269 284 269 284 <italic>D. melanogaster</italic>
###xml 307 311 307 311 <italic>SLF4</italic>
###xml 313 321 313 321 <xref ref-type="fig" rid="f1">Fig 1A,B</xref>
###xml 325 326 325 326 <italic>n</italic>
###xml 397 402 397 402 <italic>et al</italic>
###xml 393 408 393 408 <xref ref-type="bibr" rid="b26">Yan <italic>et al</italic>, 1996</xref>
###xml 412 413 412 413 <bold>B</bold>
###xml 615 619 615 619 <sup>Tuml</sup>
###xml 779 780 779 780 <bold>C</bold>
###xml 814 815 814 815 <italic>n</italic>
###xml 936 937 936 937 <italic>n</italic>
###xml 1039 1040 1039 1040 <bold>D</bold>
###xml 1093 1094 1093 1094 <bold>E</bold>
###xml 1278 1288 1278 1288 <italic>2x2Draf 3n</italic>
###xml 1303 1305 1303 1305 <italic>4n</italic>
###xml 1317 1318 1317 1318 <bold>E</bold>
###xml 1398 1399 1398 1399 <bold>D</bold>
###xml 1516 1520 1516 1520 <sup>Tuml</sup>
###xml 1590 1597 1590 1597 <italic>Renilla</italic>
###xml 1676 1677 1676 1677 <bold>F</bold>
###xml 269 284 <span type="species:ncbi:7227">D. melanogaster</span>
Drosophila Stat binds to 3n and 4n sites with various affinities. (A) Sequences of the oligonucleotides used in (B,C,F). SB1, SB2 and SB3 correspond to the potential Stat-binding sites present in the SB fragment (Fig 1A), and Dome3, Dome4 and Dome3+4 correspond to the D. melanogaster Stat-binding sites in SLF4 (Fig 1A,B). 3n wild type (WT) corresponds to the Stat92E-binding site consensus (Yan et al, 1996). (B) EMSA assay using the radiolabelled binding sites indicated and showing binding activities that are detectable after co-transfection of plasmids expressing Stat92E-GFP and the constitutively active HopTuml proteins. Specific shifted bands corresponding to DNA:Stat92E-GFP (arrow) and DNA:Stat92E-GFP complexes supershifted with anti-GFP (arrowhead) are indicated. (C) EMSA assay using radiolabelled 3n WT to detect activated Stat92E-GFP-binding activity. Each lane contains the same quantity of cell extract and labelled 3n WT-binding site and was co-incubated with the indicated fold excess of unlabelled competitor sites. (D) Schematic representation of the reporters used in (E) with black boxes representing Stat-binding sites. Underlined bases represent the core Stat92E-binding sequence. Another thymine residue (bold) was inserted into each binding site of 2x2Draf 3n to create the 4n reporter. (E) Firefly luciferase activity in cells transfected with the reporters shown in (D) and co-transfected with plasmids expressing either the pathway ligand unpaired or the constitutively active Jak HopTuml. Levels were normalized to a co-transfected constitutively expressed Renilla luciferase plasmid and are expressed as fold change over unstimulated state. (F) EMSA assay of unactivated and activated Stat92E-GFP binding to radiolabelled WT, SB1, SB2 and SB3 oligonucleotides. EMSA, electrophoretic mobility shift assay; GFP, green fluorescent protein; MUT, mutated; STAT, signal transducer and activator of transcription.
###end p 62
###begin p 63
###xml 35 42 35 42 <italic>in vivo</italic>
###xml 72 73 72 73 <bold>A</bold>
###xml 103 107 103 107 <italic>SLF4</italic>
###xml 140 141 140 141 <italic>n</italic>
###xml 142 159 142 159 <italic>n D. melanogaster</italic>
###xml 181 182 181 182 <bold>B</bold>
###xml 210 214 210 214 <italic>SLF4</italic>
###xml 260 261 260 261 <italic>n</italic>
###xml 286 287 286 287 <italic>n</italic>
###xml 290 291 290 291 <bold>C</bold>
###xml 296 300 296 300 <italic>SLF4</italic>
###xml 359 360 359 360 <italic>n</italic>
###xml 377 378 377 378 <italic>n</italic>
###xml 458 459 458 459 <bold>C</bold>
###xml 486 487 486 487 <bold>B</bold>
###xml 520 521 520 521 <bold>A</bold>
###xml 144 159 <span type="species:ncbi:7227">D. melanogaster</span>
Various Stat spacer lengths modify in vivo transcriptional activation. (A) Levels of expression of the SLF4 enhancer containing the normal 4n4n D. melanogaster Stat-binding sites. (B) Enhanced expression of an SLF4 enhancer in which the conserved fourth Stat 4n site is transformed to 3n. (C) An SLF4 enhancer in which the third site has been transformed to 2n and there is a 3n site transformation on the fourth site. Note that the levels of expression in (C) are lower than those in (B), and more similar to those of (A). Stat, signal transducer and activator of transcription.
###end p 63
###begin p 64
###xml 4 7 4 7 <italic>crb</italic>
###xml 43 44 43 44 <italic>n</italic>
###xml 53 54 53 54 <bold>A</bold>
###xml 88 91 88 91 <italic>crb</italic>
###xml 208 209 208 209 <italic>n</italic>
###xml 235 236 235 236 <italic>n</italic>
###xml 246 247 246 247 <bold>B</bold>
###xml 304 305 304 305 <bold>C</bold>
###xml 333 334 333 334 <italic>n</italic>
###xml 335 336 335 336 <italic>n</italic>
###xml 337 338 337 338 <italic>n</italic>
###xml 356 357 356 357 <bold>D</bold>
###xml 378 379 378 379 <italic>n</italic>
###xml 395 396 395 396 <italic>n</italic>
###xml 397 398 397 398 <italic>n</italic>
###xml 402 403 402 403 <bold>E</bold>
###xml 431 432 431 432 <italic>n</italic>
###xml 433 434 433 434 <italic>n</italic>
###xml 450 451 450 451 <italic>n</italic>
The crb gene is regulated by Stat through 4n sites. (A) Schematic representation of the crb gene showing the localization in the spiracle enhancer of the putative Stat-binding sites analysed (red asterisks (4n sites), black asterisk (3n site)). (B) Expression of the spiracle enhancer in the wild type. (C) Expression in the triple 3n4n4n mutant (- - -). (D) Expression in the 3n mutant site (-4n4n). (E) Expression in the double 4n4n mutant sites (3n- -). Stat, signal transducer and activator of transcription.
###end p 64

